OSSFF (Embla Medical hf) Interest Expense: $-20.7 Mil (TTM As of Mar. 2026)

What is Embla Medical hf Interest Expense?

Embla Medical hf OSSFF 92 Interest Expense is $-20.7 Mil as of Mar. 2026. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Embla Medical hf's interest expense for the three months ended in Mar. 2026 was $ -4.9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-20.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Embla Medical hf's Operating Income for the three months ended in Mar. 2026 was $ 22.6 Mil. Embla Medical hf's Interest Expense for the three months ended in Mar. 2026 was $ -4.9 Mil. Embla Medical hf's Interest Coverage for the quarter that ended in Mar. 2026 was 4.65. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embla Medical hf (OTCPK:OSSFF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embla Medical hf's Interest Expense for the three months ended in Mar. 2026 was $-4.9 Mil. Its Operating Income for the three months ended in Mar. 2026 was $22.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $363.7 Mil.

Embla Medical hf's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	22.64	/	-4.864
	=	4.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Embla Medical hf Interest Expense Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Interest Expense can be seen below:

Embla Medical hf Interest Expense Chart

Embla Medical hf Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-9.80

-11.20

-17.96

-23.25

-19.52

Embla Medical hf Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-5.25	-5.07	-6.24	-4.56	-4.86

92GF Score

Embla Medical hf OSSFF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Embla Medical hf Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.7 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-20.7 Mil mean?

Embla Medical hf (OSSFF) has a Interest Expense of $-20.7 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Embla Medical hf and its competitors.

Is Embla Medical hf's Interest Expense too high?

Embla Medical hf's current Interest Expense is $-20.7 Mil. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.

How does Embla Medical hf's Interest Expense compare to ABT and SYK?

Embla Medical hf's Interest Expense of $-20.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Interest Expense is $-20.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Embla Medical hf stock overvalued right now?

Embla Medical hf (OSSFF) has a current Interest Expense of $-20.7 Mil. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current Interest Expense is $-20.7 Mil. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Interest Expense is $-20.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.

Key valuation signals for OSSFF:

Interest Expense: $-20.7 Mil
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OCSE:GN OCSE:CHEMM OCSE:AMBU B OCSE:VIRO OCSE:SMSMED OCSE:DEMANT ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA STE ZBH XSWX:SOON SHSE:688271

Other Exchanges 0FIW:UK EMBLA:Denmark 5IQ:Germany

Address Grjothals 5, Reykjavik, ISL

Website https://www.emblamedical.com

Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.

92GF Score

Get the complete analysis for OSSFF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15

Price

$5.49

GF Value

View OSSFF Analysis

See Interest Expense data for all stocks →